Company intelligence / Profile preview
Sol-Gel Technologies
Ness Ziona, Israelsol-gel.com ↗
- Ownership
- Public · SLGL
- Employees
- ~34
- Development stage
- Other
01
Overview
Sol-Gel has two FDA-approved topical dermatology products—TWYNEO for acne vulgaris and EPSOLAY for papulopustular rosacea—commercialized via partners. Its lead pipeline asset, SGT‑610 (patidegib gel), is in Phase 3 trials as a first-in-class topical preventive treatment for basal cell carcinomas in Gorlin syndrome. Another candidate, SGT‑210, completed Phase 1 for rare skin keratodermas. The company leverages proprietary silica-based microencapsulation to enhance efficacy and tolerability of topicals.
- Therapeutic areas
- DermatologyRare Diseases
- Modalities
- Small moleculeTopical drugPolymer-drug conjugate therapy
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Galderma Holding SASearchlight Pharma Inc.Mayne PharmaPadagis Israel Pharmaceuticals Ltd.
04
Financials
- Market cap
- $226.8M
- Total revenue
- $591K
- Enterprise value
- $179.6M
Beyond the preview
Go deeper on Sol-Gel Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sol-Gel Technologies.